InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2025-05-23 00:00:00 ET · period of report 2025-05-21 · accession 0001438133-25-000109 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-23 2025-05-22 TNDM Sodhi Rajwant Dir M - OptEx $20.64 +4,387 15.5K +39% +$90.5K
D 2025-05-23 2025-05-22 TNDM Sodhi Rajwant Dir M - OptEx $0.00 -4,387 0 -100% $0
D 2025-05-23 2025-05-21 TNDM Sodhi Rajwant Dir A - Grant $0.00 +8,759 8,759 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-22 M A 4,387 $20.64 15,521 D — —
2 Derivative Restricted Stock Unit 2025-05-22 M D 4,387 $0.00 0 D — · — to — 4,387 Common Stock (F1) Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). (F2) Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. (F3) RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
3 Derivative Restricted Stock Unit 2025-05-21 A A 8,759 $0.00 8,759 D — · — to — 8,759 Common Stock (F4) Awarded on May 21, 2025 pursuant to the 2023 Plan. (F2) Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. (F3) RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.